Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Bacillus Calmette-Guérin treatment of urothelial carcinoma arising in the ileal neobladder after radical cystectomy.

Yamashita R, Matsuzaki M, Niwakawa M, Ito I.

Int J Urol. 2014 Mar;21(3):333-4. doi: 10.1111/iju.12268. Epub 2013 Sep 1.

3.

Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.

Giannarini G, Birkhäuser FD, Recker F, Thalmann GN, Studer UE.

Eur Urol. 2014 Apr;65(4):825-31. doi: 10.1016/j.eururo.2013.09.049. Epub 2013 Oct 9.

PMID:
24144432
4.
5.

[A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder].

Obayashi K, Miki J, Kasai K, Tashiro K, Tsuduki S, Bando S, Ishii G, Suzuki K, Kimura T, Kishimoto K, Egawa S.

Hinyokika Kiyo. 2014 Sep;60(9):443-6. Review. Japanese.

6.

Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy.

Lee JY, Diaz RR, Cho KS, Lim MS, Chung JS, Kim WT, Ham WS, Choi YD.

J Urol. 2013 Oct;190(4):1192-9. doi: 10.1016/j.juro.2013.04.077. Epub 2013 May 3.

PMID:
23648222
7.
8.

Cystectomy with orthotopic ileal neobladder reconstruction for treatment of bladder contracture after intravesical bacillus Calmette-Guerin therapy.

Vetorazzo Filho JE, Bahia LA, Vedovato BC, Maron PE, Esteves PE, Fernandes Rde C, Perez MD.

Einstein (Sao Paulo). 2014 Oct-Dec;12(4):502-4. doi: 10.1590/S1679-45082014RC2794. Epub 2014 Nov 18. English, Portuguese.

10.

Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.

Spaliviero M, Dalbagni G, Bochner BH, Poon BY, Huang H, Al-Ahmadie HA, Donahue TF, Taylor JM, Meeks JJ, Sjoberg DD, Donat SM, Reuter VE, Herr HW.

J Urol. 2014 Sep;192(3):702-7. doi: 10.1016/j.juro.2014.02.2565. Epub 2014 Mar 3.

11.

[Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].

Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF.

Zhonghua Wai Ke Za Zhi. 2005 Nov 15;43(22):1457-60. Chinese.

PMID:
16318813
12.

[Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].

Fujimoto K, Chihara Y, Kondo H, Hirao Y.

Hinyokika Kiyo. 2006 Jun;52(6):433-8. Japanese.

13.

[Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report].

Muranaka T, Kunishima Y, Shigyo M, Kato R, Masumori N, Ito N, Tsukamoto T, Takagi Y, Seki M, Toida I.

Hinyokika Kiyo. 2007 Aug;53(8):581-4. Japanese.

14.

Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.

Cheng CW, Chan SF, Chan LW, Chan CK, Ng CF, Cheung HY, Chan SY, Wong WS, Lai FM, To KF, Li ML.

Int J Urol. 2005 May;12(5):449-55.

15.

Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.

Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.

Eur Urol. 2005 Jul;48(1):53-9; discussion 59. Epub 2005 Apr 7.

PMID:
15967252
16.

Carcinoma in situ developing in an ileal neobladder.

Ide H, Kikuchi E, Shinoda K, Mukai M, Murai M.

Urology. 2007 Mar;69(3):576.e9-11. Review.

PMID:
17382181
17.

[Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].

Yi SH, Ye G, Wang XW, Jin HS, Zhang YN, Yan ZL.

Ai Zheng. 2008 Nov;27(11):1208-11. Chinese.

PMID:
19000455
19.
20.

Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.

Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED.

J Urol. 2007 May;177(5):1727-31.

PMID:
17437798

Supplemental Content

Support Center